ClinicalThought

Share

Program Content

Activities

  • RR MM Conversations
    How We Select Treatment in R/R Myeloma: A Conversation With 3 Experts
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 29, 2021

    Expires: March 28, 2022

Faculty

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Saad Z. Usmani, MD, MBA, FACP

Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
Professor
Weill Cornell Medical College, Cornell University
New York, New York

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Bristol Myers Squibb

Janssen administered by Scientific Affairs

Oncopeptides